<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Adv Biomed Res</journal-id><journal-id journal-id-type="iso-abbrev">Adv Biomed Res</journal-id><journal-id journal-id-type="publisher-id">ABR</journal-id><journal-title-group><journal-title>Advanced Biomedical Research</journal-title></journal-title-group><issn pub-type="ppub">2277-9175</issn><issn pub-type="epub">2277-9175</issn><publisher><publisher-name>Medknow Publications &amp; Media Pvt Ltd</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25250297</article-id><article-id pub-id-type="pmc">4166055</article-id><article-id pub-id-type="publisher-id">ABR-3-183</article-id><article-id pub-id-type="doi">10.4103/2277-9175.140088</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of hypertonic saline on hypotension following induction of general anesthesia: A randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kashefi</surname><given-names>Parviz</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Montazeri</surname><given-names>Kamran</given-names></name><xref ref-type="aff" rid="aff1"></xref></contrib><contrib contrib-type="author"><name><surname>Hashemi</surname><given-names>Seyed Taghi</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1">Department of Anesthesia, Medical School, St-Alzahra Medical Center, Isfahan University of Medical Sciences, Isfahan, Iran</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Seyed Taghi Hashemi, Department of Anesthesia, Medical School, St-Alzahra Medical Center, Isfahan University of Medical Sciences, Isfahan, Iran. E-mail: <email xlink:href="st_hashemi@yahoo.com">st_hashemi@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>04</day><month>9</month><year>2014</year></pub-date><volume>3</volume><elocation-id>183</elocation-id><history><date date-type="received"><day>27</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>18</day><month>6</month><year>2014</year></date></history><permissions><copyright-statement>Copyright: © 2014 Kashefi.</copyright-statement><copyright-year>2014</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="3119" xml_f="3130" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="3141" xml_f="3301" txt_i="23" txt_f="183">The aim of this study was to examine the effects of preoperatively administered i.v. hypertonic saline on hypotension following induction of general anesthesia.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3332" xml_f="3354" txt_i="185" txt_f="207">Materials and Methods:</offsets></title><p><offsets xml_i="3365" xml_f="3887" txt_i="208" txt_f="730">Fifty-four patients who scheduled for elective surgery were randomly allocated to two groups of 27 patients who received hypertonic saline 5% (2.3 ml/kg) or received normal saline (13 ml/kg). Infusion of hypertonic saline was done half an hour before induction of anesthesia during 30 minutes. Anesthesia was conducted in a standard protocol for all patients. Age, sex, body mass index (BMI), systolic and diastolic blood pressure (SBP, DBP), heart rate (HR) and mean arterial pressure (MAP) were assessed in all patients.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3918" xml_f="3926" txt_i="732" txt_f="740">Results:</offsets></title><p><offsets xml_i="3937" xml_f="4199" txt_i="741" txt_f="1003">The mean age of patients was 36.68 ± 10.8 years. Forty percent of patients were male. The mean SBP at min 2 and min 5, mean of DBP at min 2, 5, and 15, mean of HR at all time points and mean of MAP at min 2 and 15 between groups were no significantly different (</offsets><italic><offsets xml_i="4207" xml_f="4208" txt_i="1003" txt_f="1004">P</offsets></italic><offsets xml_i="4217" xml_f="4392" txt_i="1004" txt_f="1176"> &gt; 0.05), but mean of SBP at min 10 and 15, mean of DBP at min 10, and mean of MAP at min 5 and 10 in hypertonic saline group was significantly more than the normal group (</offsets><italic><offsets xml_i="4400" xml_f="4401" txt_i="1176" txt_f="1177">P</offsets></italic><offsets xml_i="4410" xml_f="4502" txt_i="1177" txt_f="1266"> &lt; 0.05). Trend of SBP, DBP, HR and MAP between groups were not significantly different (</offsets><italic><offsets xml_i="4510" xml_f="4511" txt_i="1266" txt_f="1267">P</offsets></italic><offsets xml_i="4520" xml_f="4532" txt_i="1267" txt_f="1276"> &gt; 0.05).</offsets></p></sec><sec id="st4"><title><offsets xml_i="4563" xml_f="4575" txt_i="1278" txt_f="1290">Conclusions:</offsets></title><p><offsets xml_i="4586" xml_f="4757" txt_i="1291" txt_f="1462">Infusion of hypertonic saline 5% (2.3 mg/kg) before the general anesthesia led to a useful reduction in MAP and reduced heart rate, with no episodes of severe hypotension.</offsets></p></sec></abstract><kwd-group><kwd>Blood pressure</kwd><kwd>general anesthesia</kwd><kwd>hypertonic saline</kwd><kwd>hypotension</kwd><kwd>mean arterial pressure
</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="5009" xml_f="5021" txt_i="1471" txt_f="1483">INTRODUCTION</offsets></title><p><offsets xml_i="5032" xml_f="5200" txt_i="1484" txt_f="1652">General anesthesia is often preferred because of the discomfort and incomplete block that may accompany topical anesthesia as well as providing hypotensive anesthesia.[</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5233" xml_f="5234" txt_i="1652" txt_f="1653">1</offsets></xref><offsets xml_i="5241" xml_f="5298" txt_i="1653" txt_f="1710">] Hypotension is commonly encountered during anesthesia.[</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="5331" xml_f="5332" txt_i="1710" txt_f="1711">2</offsets></xref><xref rid="ref3" ref-type="bibr"><offsets xml_i="5372" xml_f="5373" txt_i="1711" txt_f="1712">3</offsets></xref><offsets xml_i="5380" xml_f="5580" txt_i="1712" txt_f="1912">] Drugs are the main causes of hypotension during anesthesia, such as intravenous induction agents or inhalational agents, regional anesthesia, hypovolemia due to bleeding and dehydration, and so on.[</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="5613" xml_f="5614" txt_i="1912" txt_f="1913">3</offsets></xref><xref rid="ref4" ref-type="bibr"><offsets xml_i="5654" xml_f="5655" txt_i="1913" txt_f="1914">4</offsets></xref><offsets xml_i="5662" xml_f="5835" txt_i="1914" txt_f="2087">] Hypotension and bradycardia following induction of general anesthesia may lead to insufficient organ perfusion such a degree as to result in irreversible ischemic damage.[</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="5868" xml_f="5869" txt_i="2087" txt_f="2088">4</offsets></xref><xref rid="ref5" ref-type="bibr"><offsets xml_i="5909" xml_f="5910" txt_i="2088" txt_f="2089">5</offsets></xref><offsets xml_i="5917" xml_f="5918" txt_i="2089" txt_f="2090">]</offsets></p><p><offsets xml_i="5925" xml_f="6046" txt_i="2091" txt_f="2212">Fluid preloading which is usually well tolerated by healthy patients is commonly used for the prevention of hypotension.[</offsets><xref rid="ref6" ref-type="bibr"><offsets xml_i="6079" xml_f="6080" txt_i="2212" txt_f="2213">6</offsets></xref><xref rid="ref7" ref-type="bibr"><offsets xml_i="6120" xml_f="6121" txt_i="2213" txt_f="2214">7</offsets></xref><offsets xml_i="6128" xml_f="6498" txt_i="2214" txt_f="2584">] Hypertonic saline (HS) which refers to any saline solution with a concentration of sodium chloride greater than physiologic saline (0.9%) has been extensively investigated in animal models with regard to its efficacy in treating hemorrhagic hypotension. Also, it can be used as a continuous infusion or in bolus form to prevent and/or treat intracranial hypertension.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="6531" xml_f="6532" txt_i="2584" txt_f="2585">8</offsets></xref><offsets xml_i="6539" xml_f="6747" txt_i="2585" txt_f="2793">] The infusion of a small volume of a hypertonic solution is an option to increase blood volume and to improve hemodynamics as well as organ blood flow under conditions of hemorrhagic shock and brain trauma.[</offsets><xref rid="ref9" ref-type="bibr"><offsets xml_i="6780" xml_f="6781" txt_i="2793" txt_f="2794">9</offsets></xref><xref rid="ref10" ref-type="bibr"><offsets xml_i="6822" xml_f="6824" txt_i="2794" txt_f="2796">10</offsets></xref><xref rid="ref11" ref-type="bibr"><offsets xml_i="6865" xml_f="6867" txt_i="2796" txt_f="2798">11</offsets></xref><offsets xml_i="6874" xml_f="7252" txt_i="2798" txt_f="3176">] Infusion of HS causes intravascular and interstitial fluid volume expansion due to its high osmolality, thus improving the hemodynamics; the suggested mechanisms were a direct myocardial stimulation with high cardiac output maintenance, increase of intravascular volume, and subsequent peripheral arterial vasodilatation, increased renal blood flow, reduced sympathetic tone.[</offsets><xref rid="ref5" ref-type="bibr"><offsets xml_i="7285" xml_f="7286" txt_i="3176" txt_f="3177">5</offsets></xref><xref rid="ref12" ref-type="bibr"><offsets xml_i="7327" xml_f="7329" txt_i="3177" txt_f="3179">12</offsets></xref><xref rid="ref13" ref-type="bibr"><offsets xml_i="7370" xml_f="7372" txt_i="3179" txt_f="3181">13</offsets></xref><xref rid="ref14" ref-type="bibr"><offsets xml_i="7413" xml_f="7415" txt_i="3181" txt_f="3183">14</offsets></xref><offsets xml_i="7422" xml_f="7423" txt_i="3183" txt_f="3184">]</offsets></p><p><offsets xml_i="7430" xml_f="7611" txt_i="3185" txt_f="3366">HS affected rapid and short lasting and before anesthesia could be a suitable fluid for preloading. Therefore, it could be a suitable fluid for preloading before spinal anesthesia.[</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="7645" xml_f="7647" txt_i="3366" txt_f="3368">15</offsets></xref><xref rid="ref16" ref-type="bibr"><offsets xml_i="7688" xml_f="7690" txt_i="3368" txt_f="3370">16</offsets></xref><offsets xml_i="7697" xml_f="8084" txt_i="3370" txt_f="3757">] Clinical use of HS solutions, despite further trials, remains inconsistent and few clinical guidelines exist, and only a few studies have been performed on the use of HS solution before anesthesia. So, this randomized, placebo-controlled, study was designed to assess the effect of preoperatively administered i.v. HS technique on hypotension following induction of general anesthesia.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="8147" xml_f="8168" txt_i="3759" txt_f="3780">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="8179" xml_f="9067" txt_i="3781" txt_f="4669">In this randomized trial 54 patients who scheduled for elective surgery were randomly allocated according to a list of random digits to two groups of 27 patients after obtaining an institutional study approval from the ethics committee of Isfahan University of Medical Sciences and written informed consent from all patients. Patients of any gender aged between 18 and 50 years old who scheduled to undergo elective surgery with American Society of Anesthesiologists classification I and II were eligible, if they had no history of chronic disease, no use of NSAIDs drugs up to 2 weeks before surgery, no uncontrolled systemic hypertension, no preoperative treatment for hypertension, no ischemic heart disease with clinical symptoms, no history use of opioids. Also, patients with hemodynamic instability (active bleeding, hypovolemia or loss of body fluid) were excluded from the study.</offsets></p><p><offsets xml_i="9074" xml_f="9548" txt_i="4670" txt_f="5144">At the night before surgery all patients remain NPO for a minimum of 8 hours before scheduled elective surgery, and all patients were premedicated with 0.1 mg/kg diazepam. In the operating room, a 16-gauge cannula was inserted in a peripheral vein in the cubital fossa. Patients in group HS received 2.3 mg/kg of HS 5%. Also, patients in group normal saline (NS) received 13 mg/kg of NS. Infusion of HS was done half an hour before induction of anesthesia during 30 minutes.</offsets></p><p><offsets xml_i="9555" xml_f="10198" txt_i="5145" txt_f="5788">Anesthesia was conducted using a total i.v. technique consisting of infusion of fentanyl (2 mcg/kg), sodium thiopental (5 mg/kg) and atracurium (0.5 mg/kg). Endotracheal intubation was performed with a single-lumen tube. Balanced anesthesia was maintained using with inhalation of isoflurane (1-2%) and morphine (0.1 mg/kg). Patients’ lungs were mechanically ventilated with the same setting during ventilation (VT, 10 mL/kg and RR, 10 min). Ventilation was controlled to maintain end-tidal CO2 35 to 40 mmHg. The patients were monitored and observed using an electrocardiogram, non-invasive arterial blood pressure device, and pulse oximeter.</offsets></p><p><offsets xml_i="10205" xml_f="10717" txt_i="5789" txt_f="6301">Age, sex, body mass index (BMI) as demographic and clinical parameters including systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate and mean arterial pressure (MAP) were assessed in all patients. SBP, DBP, heart rate (HR) and MAP were measured non-invasively before injection of study drugs and 2, 5, 10 and 15 minutes after injection of study drugs in all patients. Also, in each time points SBP, DBP, heart rate and MAP were measured three times, and the mean values used as final value.</offsets></p><p><offsets xml_i="10724" xml_f="11337" txt_i="6302" txt_f="6915">The sample size was calculated using the comparison of means formula with two-sided log-rank test, α = 0.05, and 80% power. All collected data were analyzed using SPSS-20 software. Variables were presented as mean ± SD, and number (percent). Age, BMI, duration of anesthesia, SBP, DBP, heart rate and MAP compared between study groups by the independent sample t-test. The Chi-square test was used to assess sex combination between groups, and also trend of SBP, DBP, heart rate and MAP at time points were compared between study groups by repeated amusements of ANOVA. Statistical significance was accepted at a </offsets><italic><offsets xml_i="11345" xml_f="11346" txt_i="6915" txt_f="6916">P</offsets></italic><offsets xml_i="11355" xml_f="11366" txt_i="6916" txt_f="6924"> &lt; 0.05.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="11419" xml_f="11426" txt_i="6926" txt_f="6933">RESULTS</offsets></title><p><xref ref-type="fig" rid="F1"><offsets xml_i="11467" xml_f="11475" txt_i="6934" txt_f="6942">Figure 1</offsets></xref><offsets xml_i="11482" xml_f="11804" txt_i="6942" txt_f="7264"> shows the flowchart of study. As shown of 60 patients who assessed for eligibility, 6 patients did not enter to the study; 4 patients did not meet the inclusion criteria and 2 patients refused informed consent. Finally, 54 patients entered the study, randomly divided to the study group, completed the study and analyzed.</offsets></p><fig id="F1" position="float"><label><offsets xml_i="11845" xml_f="11853" txt_i="7265" txt_f="7273">Figure 1</offsets></label><caption><p><offsets xml_i="11873" xml_f="11888" txt_i="7273" txt_f="7288">Study flowchart</offsets></p></caption><graphic xlink:href="ABR-3-183-g001"></graphic></fig><p><offsets xml_i="11958" xml_f="12131" txt_i="7289" txt_f="7462">Total mean age of the studied patients was 36.68 ± 10.8 years old, the mean BMI of 26.12 ± 4.11. Of 54 studied patient 22 (40.1%) were males and 32 (59.9%) were females. In </offsets><xref ref-type="table" rid="T1"><offsets xml_i="12163" xml_f="12170" txt_i="7462" txt_f="7469">Table 1</offsets></xref><offsets xml_i="12177" xml_f="12439" txt_i="7469" txt_f="7731">, baseline characteristics and clinical parameters in studies patients are compared to one another among the studied groups, based on the results of which there was no statistically significant difference in regard to these variables between the studied groups (</offsets><italic><offsets xml_i="12447" xml_f="12448" txt_i="7731" txt_f="7732">P</offsets></italic><offsets xml_i="12457" xml_f="12469" txt_i="7732" txt_f="7741"> &gt; 0.05).</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="12517" xml_f="12524" txt_i="7742" txt_f="7749">Table 1</offsets></label><caption><p><offsets xml_i="12544" xml_f="12625" txt_i="7749" txt_f="7830">Baseline characteristics and clinical parameters in 54 studies patients by groups</offsets></p></caption><graphic xlink:href="ABR-3-183-g002"></graphic></table-wrap><p><xref ref-type="table" rid="T2"><offsets xml_i="12734" xml_f="12741" txt_i="7831" txt_f="7838">Table 2</offsets></xref><offsets xml_i="12748" xml_f="13015" txt_i="7838" txt_f="8105"> shows the comparison of clinical parameters between studied groups. As shown, SBP at time points (min 2,5,10 and 15) in the HS group was higher than the NS group. The mean of SBP at min 2 and 5 between groups was similar and no significant differences was observed (</offsets><italic><offsets xml_i="13023" xml_f="13024" txt_i="8105" txt_f="8106">P</offsets></italic><offsets xml_i="13033" xml_f="13145" txt_i="8106" txt_f="8215"> &gt; 0.05), but at min 10 and 15, the mean of SBP in the HS group was significantly more than the other group (</offsets><italic><offsets xml_i="13153" xml_f="13154" txt_i="8215" txt_f="8216">P</offsets></italic><offsets xml_i="13163" xml_f="13282" txt_i="8216" txt_f="8332"> &lt; 0.05). The differences in the mean of DBP at min 2, 5, and 15 were not statistically significant between groups (</offsets><italic><offsets xml_i="13290" xml_f="13291" txt_i="8332" txt_f="8333">P</offsets></italic><offsets xml_i="13300" xml_f="13399" txt_i="8333" txt_f="8429"> &gt; 0.05). But at min 10 mean of DBP in the HS group was significantly higher than the NS group (</offsets><italic><offsets xml_i="13407" xml_f="13408" txt_i="8429" txt_f="8430">P</offsets></italic><offsets xml_i="13417" xml_f="13531" txt_i="8430" txt_f="8544"> = 0.022). The mean of HR at time points between groups were similar and no significant differences was observed (</offsets><italic><offsets xml_i="13539" xml_f="13540" txt_i="8544" txt_f="8545">P</offsets></italic><offsets xml_i="13549" xml_f="13643" txt_i="8545" txt_f="8636"> &gt; 0.05). The mean of MAP at min 2 and 15 between groups were not significantly different (</offsets><italic><offsets xml_i="13651" xml_f="13652" txt_i="8636" txt_f="8637">P</offsets></italic><offsets xml_i="13661" xml_f="13774" txt_i="8637" txt_f="8747"> &gt; 0.05), but at min 5 and 10, the mean of MAP in the HS group was significantly higher than the other group (</offsets><italic><offsets xml_i="13782" xml_f="13783" txt_i="8747" txt_f="8748">P</offsets></italic><offsets xml_i="13792" xml_f="13924" txt_i="8748" txt_f="8877"> &lt; 0.05). Trend of SBP, DBP, HR and MAP between groups were assessed by repeated amusements of ANOVA and results are reported in </offsets><xref ref-type="fig" rid="F2"><offsets xml_i="13954" xml_f="13962" txt_i="8877" txt_f="8885">Figure 2</offsets></xref><offsets xml_i="13969" xml_f="14097" txt_i="8885" txt_f="9013">. As shown trends of SBP, DBP, HR and MAP in both groups were similar and no significant differences were noted between groups (</offsets><italic><offsets xml_i="14105" xml_f="14106" txt_i="9013" txt_f="9014">P</offsets></italic><offsets xml_i="14115" xml_f="14127" txt_i="9014" txt_f="9023"> &gt; 0.05).</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="14175" xml_f="14182" txt_i="9024" txt_f="9031">Table 2</offsets></label><caption><p><offsets xml_i="14202" xml_f="14291" txt_i="9031" txt_f="9120">Comparison of clinical parameters in 54 patients at time points in regard to study groups</offsets></p></caption><graphic xlink:href="ABR-3-183-g003"></graphic></table-wrap><fig id="F2" position="float"><label><offsets xml_i="14402" xml_f="14410" txt_i="9121" txt_f="9129">Figure 2</offsets></label><caption><p><offsets xml_i="14430" xml_f="14827" txt_i="9129" txt_f="9526">Compare of trend of studied variables in time points between the hypertonic saline group and normal saline group. SBP = Systolic blood pressure, DBP = Diastolic blood pressure, HR = Heart rate, MAP = Mean arterial pressure Statistical analyses were done using repeated amusements of ANOVA and no significant differences were noted between groups for trend of SBP, DBP, HR, and MAP at time points (</offsets><italic><offsets xml_i="14835" xml_f="14836" txt_i="9526" txt_f="9527">P</offsets></italic><offsets xml_i="14845" xml_f="14856" txt_i="9527" txt_f="9535"> &gt; 0.05)</offsets></p></caption><graphic xlink:href="ABR-3-183-g004"></graphic></fig></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="14975" xml_f="14985" txt_i="9537" txt_f="9547">DISCUSSION</offsets></title><p><offsets xml_i="14996" xml_f="15188" txt_i="9548" txt_f="9740">During induction of general anesthesia, patients with hypertension may exhibit significant increases in heart rate and blood pressure, though the agents used for this often cause hypotension.[</offsets><xref rid="ref17" ref-type="bibr"><offsets xml_i="15222" xml_f="15224" txt_i="9740" txt_f="9742">17</offsets></xref><offsets xml_i="15231" xml_f="15323" txt_i="9742" txt_f="9834">] A frequent complication of anesthesia is arterial hypotension after anesthetic induction.[</offsets><xref rid="ref18" ref-type="bibr"><offsets xml_i="15357" xml_f="15359" txt_i="9834" txt_f="9836">18</offsets></xref><xref rid="ref19" ref-type="bibr"><offsets xml_i="15400" xml_f="15402" txt_i="9836" txt_f="9838">19</offsets></xref><xref rid="ref20" ref-type="bibr"><offsets xml_i="15443" xml_f="15445" txt_i="9838" txt_f="9840">20</offsets></xref><offsets xml_i="15452" xml_f="16041" txt_i="9840" txt_f="10429">] In this randomized study we assessed the effect of preoperatively administered i.v. HS on hypotension following induction of general anesthesia in 54 scheduled elective surgeries. Based on our results, the HS group as case group received 2.3 mg/kg of HS 5% before the induction of anesthesia, show a steady and smooth reduction in MAP and reduced heart rate, with no episodes of severe hypotension. When the HS infusion was stopped, which can occur with hypotensive anesthesia techniques using arterial vasodilators, rebound hypertension was not observed in any patients in the HS group.</offsets></p><p><offsets xml_i="16048" xml_f="16337" txt_i="10430" txt_f="10719">HS was chosen as it is a vasodilator with minimal myocardial depression and important advantages, such as, reduction in post resuscitation complications (renal failure, coagulopathies), and acute respiratory distress syndrome, possibly by modulation of the systemic inflammatory response.[</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="16371" xml_f="16373" txt_i="10719" txt_f="10721">21</offsets></xref><xref rid="ref22" ref-type="bibr"><offsets xml_i="16414" xml_f="16416" txt_i="10721" txt_f="10723">22</offsets></xref><xref rid="ref23" ref-type="bibr"><offsets xml_i="16457" xml_f="16459" txt_i="10723" txt_f="10725">23</offsets></xref><xref rid="ref24" ref-type="bibr"><offsets xml_i="16500" xml_f="16502" txt_i="10725" txt_f="10727">24</offsets></xref><xref rid="ref25" ref-type="bibr"><offsets xml_i="16543" xml_f="16545" txt_i="10727" txt_f="10729">25</offsets></xref><xref rid="ref26" ref-type="bibr"><offsets xml_i="16586" xml_f="16588" txt_i="10729" txt_f="10731">26</offsets></xref><offsets xml_i="16595" xml_f="16735" txt_i="10731" txt_f="10871">] The effect of HS on cardiac function is offset by lowering of the peripheral vascular resistance, thus maintaining cardiac pump function.[</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="16769" xml_f="16771" txt_i="10871" txt_f="10873">27</offsets></xref><offsets xml_i="16778" xml_f="17049" txt_i="10873" txt_f="11144">] Evidence showing that HSS may be an effective treatment for brain edema and elevated increased intracranial pressure after head trauma, and also the beneficial effects during hemorrhagic shock in the presence of IH associated with systemic hypotension have been noted.[</offsets><xref rid="ref28" ref-type="bibr"><offsets xml_i="17083" xml_f="17085" txt_i="11144" txt_f="11146">28</offsets></xref><xref rid="ref29" ref-type="bibr"><offsets xml_i="17126" xml_f="17128" txt_i="11146" txt_f="11148">29</offsets></xref><xref rid="ref30" ref-type="bibr"><offsets xml_i="17169" xml_f="17171" txt_i="11148" txt_f="11150">30</offsets></xref><xref rid="ref31" ref-type="bibr"><offsets xml_i="17212" xml_f="17214" txt_i="11150" txt_f="11152">31</offsets></xref><offsets xml_i="17221" xml_f="17379" txt_i="11152" txt_f="11310">] The impact of HS on hypotension following induction of general anesthesia has not been well studied; however, in a randomized double-blind study by Jarvela </offsets><italic><offsets xml_i="17387" xml_f="17392" txt_i="11310" txt_f="11315">et al</offsets></italic><offsets xml_i="17401" xml_f="17403" txt_i="11315" txt_f="11317">.[</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="17436" xml_f="17437" txt_i="11317" txt_f="11318">8</offsets></xref><offsets xml_i="17444" xml_f="17725" txt_i="11318" txt_f="11599">] the effect of 75 mg/ml (7.5%) HS on extracellular water volume and hematocrit in patients under spinal anesthesia was evaluated and results show that HS is an alternative for preloading before spinal anesthesia in situations where excess free water administration is not desired.</offsets></p><p><offsets xml_i="17732" xml_f="18125" txt_i="11600" txt_f="11993">The development of neurologic complications due to osmotic demyelination syndrome is the most serious theoretical complication of HS therapy and also because of induces a rapid change in serum sodium concentration after infusion of HS some risks may include. Central pontine myelinolysis is a hazardous complication that is more likely to occur after rapid correction of chronic hyponatremia.[</offsets><xref rid="ref32" ref-type="bibr"><offsets xml_i="18159" xml_f="18161" txt_i="11993" txt_f="11995">32</offsets></xref><offsets xml_i="18168" xml_f="18268" txt_i="11995" txt_f="12095">] In a large cohort of emergency patients severe hypernatremia as a result of HS has been reported,[</offsets><xref rid="ref21" ref-type="bibr"><offsets xml_i="18302" xml_f="18304" txt_i="12095" txt_f="12097">21</offsets></xref><offsets xml_i="18311" xml_f="18415" txt_i="12097" txt_f="12201">] also in some clinical trials, after the rapid infusion of HS arterial hypotension was seen initially.[</offsets><xref rid="ref33" ref-type="bibr"><offsets xml_i="18449" xml_f="18451" txt_i="12201" txt_f="12203">33</offsets></xref><xref rid="ref34" ref-type="bibr"><offsets xml_i="18492" xml_f="18494" txt_i="12203" txt_f="12205">34</offsets></xref><xref rid="ref35" ref-type="bibr"><offsets xml_i="18535" xml_f="18537" txt_i="12205" txt_f="12207">35</offsets></xref><offsets xml_i="18544" xml_f="18886" txt_i="12207" txt_f="12549">] There is no clear evidence for any adverse effects with the use of bolus doses of intravenous HS even though the question of safety is a genuine clinical concern. In the present study after the use of bolus single doses of intravenous HS no adverse effects were noted in the two groups, so, there seems to be no contraindication for HS use.</offsets></p><p><offsets xml_i="18893" xml_f="19205" txt_i="12550" txt_f="12862">The major limitations of the study were the small number of patients and performed as a single center trial and the single blind design, So more large-scale, multicenter prospective and randomized clinical studies are needed to elucidate the effect of HS on hypotension following induction of general anesthesia.</offsets></p><p><offsets xml_i="19212" xml_f="19527" txt_i="12863" txt_f="13178">In conclusion, the results of this study showed that infusion of 2.3 mg/kg of HS 5% half an hour before the induction of anesthesia during 30 minutes led to a useful and smooth reduction in MAP and reduced heart rate, with no episodes of severe hypotension. However, further studies of this technique are warranted.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support:</bold> Nil</p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest:</bold> None declared.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boezaart</surname><given-names>AP</given-names></name><name><surname>van der Merwe</surname><given-names>J</given-names></name><name><surname>Coetzee</surname><given-names>A</given-names></name></person-group><article-title>Comparison of sodium nitroprusside-and esmolol-induced controlled hypotension for functional endoscopic sinus surgery</article-title><source>Can J Anaesth</source><year>1995</year><volume>42</volume><fpage>373</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7614641</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jadon</surname><given-names>A</given-names></name></person-group><article-title>Complications of regional and general anaesthesia in obstetric practice</article-title><year>2010</year><volume>54</volume><fpage>415</fpage><lpage>20</lpage></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morris</surname><given-names>RW</given-names></name><name><surname>Watterson</surname><given-names>LM</given-names></name><name><surname>Westhorpe</surname><given-names>RN</given-names></name><name><surname>Webb</surname><given-names>RK</given-names></name></person-group><article-title>Crisis management during anaesthesia: Hypotension</article-title><source>Qual Saf Health Care</source><year>2005</year><volume>14</volume><fpage>e11</fpage><pub-id pub-id-type="pmid">15933284</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernández-Guisasola</surname><given-names>J</given-names></name><name><surname>Gómez-Arnau</surname><given-names>JI</given-names></name><name><surname>Cabrera</surname><given-names>Y</given-names></name><name><surname>del Valle</surname><given-names>SG</given-names></name></person-group><article-title>Association between nitrous oxide and the incidence of postoperative nausea and vomiting in adults: A systematic review and meta-analysis</article-title><source>Anaesthesia</source><year>2010</year><volume>65</volume><fpage>379</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">20151955</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cinèikas</surname><given-names>D</given-names></name><name><surname>Ivaškevičius</surname><given-names>J</given-names></name><name><surname>Martinkėnas</surname><given-names>JL</given-names></name><name><surname>Balseris</surname><given-names>S</given-names></name></person-group><article-title>A role of anesthesiologist in reducing surgical bleeding in endoscopic sinus surgery</article-title><source>Medicina (Kaunas)</source><year>2010</year><volume>46</volume><fpage>730</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">21467830</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watterson</surname><given-names>LM</given-names></name><name><surname>Morris</surname><given-names>RW</given-names></name><name><surname>Westhorpe</surname><given-names>RN</given-names></name><name><surname>Williamson</surname><given-names>JA</given-names></name></person-group><article-title>Crisis management during anaesthesia: Bradycardia</article-title><source>Qual Saf Health Care</source><year>2005</year><volume>14</volume><fpage>e9</fpage><pub-id pub-id-type="pmid">15933306</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smorenberg</surname><given-names>A</given-names></name><name><surname>Ince</surname><given-names>C</given-names></name><name><surname>Groeneveld</surname><given-names>AJ</given-names></name></person-group><article-title>Dose and type of crystalloid fluid therapy in adult hospitalized patients</article-title><source>Perioper Med (Lond)</source><year>2013</year><volume>2</volume><fpage>17</fpage><pub-id pub-id-type="pmid">24472418</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Järvelä</surname><given-names>K</given-names></name><name><surname>Kööbi</surname><given-names>T</given-names></name><name><surname>Kauppinen</surname><given-names>P</given-names></name><name><surname>Kaukinen</surname><given-names>S</given-names></name></person-group><article-title>Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><fpage>776</fpage><lpage>81</lpage><pub-id pub-id-type="pmid">11421840</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Himmelseher</surname><given-names>S</given-names></name></person-group><article-title>Hypertonic saline solutions for treatment of intracranial hypertension</article-title><source>Curr Opin Anaesthesiol</source><year>2007</year><volume>20</volume><fpage>414</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">17873594</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>JE</given-names></name><name><surname>Hall</surname><given-names>MJ</given-names></name></person-group><article-title>Hypertonic saline</article-title><source>J R Army Med Corps</source><year>2004</year><volume>150</volume><fpage>239</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">15732410</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bunn</surname><given-names>F</given-names></name><name><surname>Roberts</surname><given-names>I</given-names></name><name><surname>Tasker</surname><given-names>R</given-names></name><name><surname>Akpa</surname><given-names>E</given-names></name></person-group><article-title>Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients</article-title><source>Cochrane Database Syst Rev</source><year>2004</year><fpage>CD002045</fpage><pub-id pub-id-type="pmid">15266460</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>R</given-names></name><name><surname>Butler</surname><given-names>J</given-names></name></person-group><article-title>Best evidence topic reports. Hypertonic or isotonic saline in hypotensive patients with severe head injury</article-title><source>Emerg Med J</source><year>2004</year><volume>21</volume><fpage>80</fpage><lpage>1</lpage><pub-id pub-id-type="pmid">14734390</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stachenfeld</surname><given-names>NS</given-names></name></person-group><article-title>Acute effects of sodium ingestion on thirst and cardiovascular function</article-title><source>Curr Sports Med Rep</source><year>2008</year><volume>7</volume><issue>Suppl 4</issue><fpage>7</fpage><lpage>13</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monteiro-Pacheco</surname><given-names>A</given-names><suffix>Jr</suffix></name><name><surname>Martins</surname><given-names>Coimbra RS</given-names></name><name><surname>Kreimeier</surname><given-names>U</given-names></name><name><surname>Frey</surname><given-names>L</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name></person-group><article-title>Hypertonic volume therapy: Feasibility in the prevention and treatment of multiple organ failure and sepsis</article-title><source>Rev Paul Med</source><year>1995</year><volume>113</volume><fpage>1053</fpage><lpage>60</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strandvik</surname><given-names>GF</given-names></name></person-group><article-title>Hypertonic saline in critical care: A review of the literature and guidelines for use in hypotensive states and raised intracranial pressure</article-title><source>Anaesthesia</source><year>2009</year><volume>64</volume><fpage>990</fpage><lpage>1003</lpage><pub-id pub-id-type="pmid">19686485</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>BW</given-names></name><name><surname>Chiou</surname><given-names>YH</given-names></name><name><surname>Chen</surname><given-names>WB</given-names></name><name><surname>Peng</surname><given-names>TY</given-names></name><name><surname>Leung</surname><given-names>HK</given-names></name></person-group><article-title>Intravenous pretreatment of hypertonic saline can prevent systemic hypotension induced by spinal anesthesia</article-title><source>Acta Anaesthesiol Sin</source><year>1997</year><volume>35</volume><fpage>85</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">9293648</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Momota</surname><given-names>Y</given-names></name><name><surname>Kaneda</surname><given-names>K</given-names></name><name><surname>Arishiro</surname><given-names>K</given-names></name><name><surname>Kishimoto</surname><given-names>N</given-names></name><name><surname>Kanou</surname><given-names>S</given-names></name><name><surname>Kotani</surname><given-names>J</given-names></name></person-group><article-title>Changes in blood pressure during induction of anesthesia and oral and maxillofacial surgery by type and timing of discontinuation of antihypertensive drugs</article-title><source>Anesth Prog</source><year>2010</year><volume>57</volume><fpage>13</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">20331334</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pöpping</surname><given-names>DM</given-names></name><name><surname>Elia</surname><given-names>N</given-names></name><name><surname>Marret</surname><given-names>E</given-names></name><name><surname>Remy</surname><given-names>C</given-names></name><name><surname>Tramèr</surname><given-names>MR</given-names></name></person-group><article-title>Protective effects of epidural analgesia on pulmonary complications after abdominal and thoracic surgery: A meta-analysis</article-title><source>Arch Surg</source><year>2008</year><volume>143</volume><fpage>990</fpage><lpage>1000</lpage><pub-id pub-id-type="pmid">18936379</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>RJ</given-names></name><name><surname>Gatt</surname><given-names>SP</given-names></name><name><surname>Kam</surname><given-names>PC</given-names></name><name><surname>Ramzan</surname><given-names>I</given-names></name><name><surname>Daley</surname><given-names>M</given-names></name></person-group><article-title>Administration of a crystalloid fluid preload does not prevent the decrease in arterial blood pressure after induction of anaesthesia with propofol and fentanyl</article-title><source>Br J Anaesth</source><year>1998</year><volume>80</volume><fpage>737</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">9771299</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Junger</surname><given-names>WG</given-names></name><name><surname>Coimbra</surname><given-names>R</given-names></name><name><surname>Liu</surname><given-names>FC</given-names></name><name><surname>Herdon-Remelius</surname><given-names>C</given-names></name><name><surname>Junger</surname><given-names>W</given-names></name><name><surname>Junger</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>Hypertonic saline resuscitation: A tool to modulate immune function in trauma patients?</article-title><source>Shock</source><year>1997</year><volume>8</volume><fpage>235</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">9329123</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattox</surname><given-names>KL</given-names></name><name><surname>Maningas</surname><given-names>PA</given-names></name><name><surname>Moore</surname><given-names>EE</given-names></name><name><surname>Mateer</surname><given-names>JR</given-names></name><name><surname>Marx</surname><given-names>JA</given-names></name><name><surname>Aprahamian</surname><given-names>C</given-names></name><etal></etal></person-group><article-title>Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension</article-title><source>The U.S.A. multicenter trial Ann Surg</source><year>1991</year><volume>213</volume><fpage>482</fpage><lpage>91</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>YH</given-names></name><name><surname>Yu</surname><given-names>CH</given-names></name><name><surname>Chien</surname><given-names>TJ</given-names></name><name><surname>Huang</surname><given-names>RC</given-names></name><name><surname>Tan</surname><given-names>PH</given-names></name><name><surname>Cheng</surname><given-names>YS</given-names></name><etal></etal></person-group><article-title>Hypertonic saline</article-title><source>J Neurosurg</source><year>2013</year><volume>119</volume><fpage>1646</fpage><pub-id pub-id-type="pmid">24053498</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Froelich</surname><given-names>M</given-names></name><name><surname>Ni</surname><given-names>Q</given-names></name><name><surname>Wess</surname><given-names>C</given-names></name><name><surname>Ougorets</surname><given-names>I</given-names></name><name><surname>Härtl</surname><given-names>R</given-names></name></person-group><article-title>Continuous hypertonic saline therapy and the occurrence of complications in neurocritically ill patients</article-title><source>Crit Care Med</source><year>2009</year><volume>37</volume><fpage>1433</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">19242317</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Constantinides</surname><given-names>C</given-names></name><name><surname>Angeli</surname><given-names>S</given-names></name><name><surname>Mean</surname><given-names>R</given-names></name></person-group><article-title>Murine cardiac hemodynamics following manganese administration under isoflurane anesthesia</article-title><source>Ann Biomed Eng</source><year>2011</year><volume>39</volume><fpage>2706</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">21818535</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pascual</surname><given-names>JL</given-names></name><name><surname>Khwaja</surname><given-names>KA</given-names></name><name><surname>Chaudhury</surname><given-names>P</given-names></name><name><surname>Christou</surname><given-names>NV</given-names></name></person-group><article-title>Hypertonic saline and the microcirculation</article-title><source>J Trauma</source><year>2003</year><volume>54</volume><issue>Suppl 5</issue><fpage>S133</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">12768115</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakaigawa</surname><given-names>Y</given-names></name><name><surname>Akazawa</surname><given-names>S</given-names></name><name><surname>Shimizu</surname><given-names>R</given-names></name><name><surname>Ishii</surname><given-names>R</given-names></name><name><surname>Ikeno</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Effects of magnesium sulphate on the cardiovascular system, coronary circulation and myocardial metabolism in anaesthetized dogs</article-title><source>Br J Anaesth</source><year>1997</year><volume>79</volume><fpage>363</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9389857</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qureshi</surname><given-names>AI</given-names></name><name><surname>Suarez</surname><given-names>JI</given-names></name></person-group><article-title>Use of hypertonic saline solutions in treatment of cerebral edema and intracranial hypertension</article-title><source>Crit Care Med</source><year>2000</year><volume>28</volume><fpage>3301</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">11008996</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shackford</surname><given-names>SR</given-names></name><name><surname>Bourguignon</surname><given-names>PR</given-names></name><name><surname>Wald</surname><given-names>SL</given-names></name><name><surname>Rogers</surname><given-names>FB</given-names></name><name><surname>Osler</surname><given-names>TM</given-names></name><name><surname>Clark</surname><given-names>DE</given-names></name></person-group><article-title>Hypertonic saline resuscitation of patients with head injury: A prospective, randomized clinical trial</article-title><source>J Trauma</source><year>1998</year><volume>44</volume><fpage>50</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">9464749</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhardwaj</surname><given-names>A</given-names></name><name><surname>Ulatowski</surname><given-names>JA</given-names></name></person-group><article-title>Hypertonic saline solutions in brain injury</article-title><source>Curr Opin Crit Care</source><year>2004</year><volume>10</volume><fpage>126</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">15075723</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskandari</surname><given-names>R</given-names></name><name><surname>Filtz</surname><given-names>MR</given-names></name><name><surname>Davis</surname><given-names>GE</given-names></name><name><surname>Hoesch</surname><given-names>RE</given-names></name></person-group><article-title>Effective treatment of refractory intracranial hypertension after traumatic brain injury with repeated boluses of 14.6% hypertonic saline</article-title><source>J Neurosurg</source><year>2013</year><volume>119</volume><fpage>338</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">23706055</pub-id></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulger</surname><given-names>EM</given-names></name><name><surname>Hoyt</surname><given-names>DB</given-names></name></person-group><article-title>Hypertonic resuscitation after severe injury: Is it of benefit?</article-title><source>Adv Surg</source><year>2012</year><volume>46</volume><fpage>73</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">22873033</pub-id></element-citation></ref><ref id="ref32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagi</surname><given-names>R</given-names></name><name><surname>Donaldson</surname><given-names>K</given-names></name><name><surname>Loftus</surname><given-names>CM</given-names></name><name><surname>Jallo</surname><given-names>J</given-names></name></person-group><article-title>Hypertonic saline: A clinical review</article-title><source>Neurosurg Rev</source><year>2007</year><volume>30</volume><fpage>277</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">17574484</pub-id></element-citation></ref><ref id="ref33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreimeier</surname><given-names>U</given-names></name><name><surname>Messmer</surname><given-names>K</given-names></name></person-group><article-title>Small-volume resuscitation: From experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions</article-title><source>Acta Anaesthesiol Scand</source><year>2002</year><volume>46</volume><fpage>625</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">12059884</pub-id></element-citation></ref><ref id="ref34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kien</surname><given-names>ND</given-names></name><name><surname>Kramer</surname><given-names>GC</given-names></name><name><surname>White</surname><given-names>DA</given-names></name></person-group><article-title>Acute hypotension caused by rapid hypertonic saline infusion in anesthetized dogs</article-title><source>Anesth Analg</source><year>1991</year><volume>73</volume><fpage>597</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">1952141</pub-id></element-citation></ref><ref id="ref35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreimeier</surname><given-names>U</given-names></name><name><surname>Christ</surname><given-names>F</given-names></name><name><surname>Kraft</surname><given-names>D</given-names></name><name><surname>Lauterjung</surname><given-names>L</given-names></name><name><surname>Niklas</surname><given-names>M</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name><etal></etal></person-group><article-title>Anaphylaxis due to hydroxyethyl-starch-reactive antibodies</article-title><source>Lancet</source><year>1995</year><volume>346</volume><fpage>49</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">7541495</pub-id></element-citation></ref></ref-list></back></article>